Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1135 |
---|---|
High | 0.1184 |
Low | 0.1006 |
Bid | 0.103 |
Offer | 0.1045 |
Previous close | 0.28 |
Average volume | 2.79m |
---|---|
Shares outstanding | 20.19m |
Free float | 8.24m |
P/E (TTM) | -- |
Market cap | 5.65m USD |
EPS (TTM) | -0.2698 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 21:00 BST.
More ▼
- Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering
- Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications
- Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
- Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
- Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
- Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
- Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
- Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
- Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
- Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
More ▼